Use of prothrombin complex concentrates in patients with decompensated liver cirrhosis is associated with thromboembolic events

J Hepatol. 2019 Apr;70(4):800-801. doi: 10.1016/j.jhep.2018.11.019. Epub 2019 Jan 7.

Authors

Michael Tischendorf¹, Adrian Fuchs¹, Stefan Zeuzem¹, Christian M Lange²

Affiliations

¹ Medizinische Klinik 1, Klinikum der Johann Wolfgang Goethe-Universität Frankfurt, Theodor-Stern-Kai 7, Haus 11, 60590 Frankfurt, Germany.
² Medizinische Klinik 1, Klinikum der Johann Wolfgang Goethe-Universität Frankfurt, Theodor-Stern-Kai 7, Haus 11, 60590 Frankfurt, Germany. Electronic address: Christian.Lange@uk-essen.de.

PMID: 30630599
DOI: 10.1016/j.jhep.2018.11.019

No abstract available

Keywords: Coagulopathy; Liver cirrhosis; Portal vein thrombosis; Prothrombin complex concentrate.

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Anticoagulants
Blood Coagulation Factors*
Humans
Liver Cirrhosis
Liver Diseases*

Substances

Anticoagulants
Blood Coagulation Factors
prothrombin complex concentrates